News

Filter

1 to 9 of 260 results

Zubsolv market share boosts Orexo valuation, according to Edison research

Zubsolv market share boosts Orexo valuation, according to Edison research

10-02-2015

Swedish drug developer Orexo has laid the foundations to accelerate growth of its Zubsolv (buprenorphine…

FinancialMarkets & MarketingNeurologicalOrexoPharmaceuticalSwedenUSAZubsolv

Tau-based vaccines could transform early Alzheimer’s treatment, says analyst

Tau-based vaccines could transform early Alzheimer’s treatment, says analyst

27-01-2015

While current treatments for Alzheimer’s disease are only able to ease symptoms temporarily, tau-based…

AC ImmuneBiotechnologycrenezumabEli LillygantenerumabJohnson & JohnsonMarkets & MarketingNeurologicalResearchRochesolanezumabVaccines

Otsuka opens subsidiary in Australia

27-01-2015

Japanese drugmaker Otsuka Pharmaceutical has established a direct presence in Australia. A new office…

AustraliaManagementMarkets & MarketingNeurologicalOtsuka PharmaceuticalPharmaceutical

Eisai launches epilepsy treatment Exalief in Russia

Eisai launches epilepsy treatment Exalief in Russia

20-01-2015

Japanese drug major Eisai has announced that epilepsy drug Exalief (eslicarbazepine acetate) will soon…

EisaiExaliefMarkets & MarketingNeurologicalPharmaceuticalRussia

USA files suit against Omnicare for accepting kickbacks from Abbott

23-12-2014

The United States has filed a civil False Claims Act complaint against Omnicare alleging that it solicited…

Abbott LaboratoriesDepakoteLegalMarkets & MarketingNeurologicalOmnicarePharmaceuticalUSA

Court tells Actavis it must continue Namenda IR distribution

Court tells Actavis it must continue Namenda IR distribution

12-12-2014

Ireland-headquartered generic drugmaker Actavis confirmed that Judge Robert Sweet of the US District…

ActavisLegalMarkets & MarketingNamendaNeurologicalPharmaceuticalUSA

Patent cliff means pharma will lose $65 billion by 2019, says report

Patent cliff means pharma will lose $65 billion by 2019, says report

11-12-2014

Pharmaceutical companies will suffer an estimated $65 billion drop in sales by 2019 due to the patent…

AbilifyAstraZenecaEli LillyGlobalMarkets & MarketingNeurologicalOtsukaPatentsPharmaceuticalSeroquelZyprexa

Forward Pharma sues Biogen Idec over Tecfidera sales in Germany

18-11-2014

Danish biopharmaceutical company Forward Pharma has filed a law suit against US biotech major Biogen…

Biogen IdecBiotechnologyForward PharmaGermanyLegalMarkets & MarketingNeurologicalTecfidera

1 to 9 of 260 results

COMPANY SPOTLIGHT

Menarini

Back to top